Live feed
Filing
SC 13G
SC 13G0001193805-22-001435·PharmaCyte Biotech, Inc.
Schedule 13G ownership disclosure
PHARMACYTE BIOTECH INC
Security class unavailable · CUSIP: 71715X203
Event date: 2022-10-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-22-001435
- Form type
- SC 13G
- Filer
- PharmaCyte Biotech, Inc.
- CIK
- CIK 1157075
- Filed
- Oct 20, 2022
- Reporting period
- Oct 10, 2022
- Description
- Schedule 13G beneficial ownership